Literature DB >> 9462637

Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver.

T Suda1, O Isokawa, Y Aoyagi, M Nomoto, K Tsukada, T Shimizu, Y Suzuki, A Naito, H Igarashi, M Yanagi, T Takahashi, H Asakura.   

Abstract

Because telomerase activity is necessary for cell immortality and probably associated with tumor progression, we have evaluated a possible aid for quantitation of the activity to predict intrahepatic recurrences after surgery in patients with hepatocellular carcinoma (HCC). HCC tissues obtained by surgical resection from 20 patients were studied. Telomerase activity was expressed as peaks with a periodicity through a fluorescence-based telomeric repeat amplification protocol using an autosequencer, and the quantity of activity was calculated from peak areas. A ratio of fluorescence intensity depending on telomerase to that of an internal standard was used as a value of relative telomerase activity (RTA). RTA in serially diluted S100 extracts from HepG2 cells was well correlated with the amount of the extracts. The mean RTA value of 36.4 +/- 27.8 (mean +/- SD, 3.21 to 105) in 9 patients suffering from early recurrences after surgery was significantly higher than that (9.84 +/- 7.65; mean +/- SD, 3.00 to 29.0) in 11 patients without intrahepatic recurrences during the early period (P = .004). These results indicate that RTA value can be a useful predictor for intrahepatic recurrences during the early period after surgical resection of HCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462637     DOI: 10.1002/hep.510270213

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Antisense telomerase RNA induced human gastric cancer cell apoptosis.

Authors:  Fang-Xin Zhang; Xue-Yong Zhang; Dai-Ming Fan; Zi-Yun Deng; Yan Yan; Han-Ping Wu; Jun-Jie Fan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 2.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 3.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.

Authors:  Hai-Xia Qin; Ke-Jun Nan; Guang Yang; Zhao Jing; Zhi-Ping Ruan; Chun-Li Li; Rui Xu; Hui Guo; Chen-Guang Sui; Yong-Chang Wei
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 5.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 6.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.

Authors:  Atsuo Nakamura; Takeshi Suda; Terasu Honma; Toru Takahashi; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yusaku Mita; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

8.  The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.

Authors:  Xi-Xian Yao; Lei Yin; Zhong-Cheng Sun
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.

Authors:  Jia-Hua Zhou; Hong-Mei Zhang; Quan Chen; Dong-Dong Han; Fei Pei; Li-Shan Zhang; De-Tong Yang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.

Authors:  Yan-Shen Shan; Yu-Hsiang Hsieh; Pin-Wen Lin
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.